Bioinformatics and Computational Biology in Human Diseases

A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Bioinformatics".

Deadline for manuscript submissions: closed (15 August 2023) | Viewed by 329

Special Issue Editor


E-Mail Website
Guest Editor
Department of Cancer Biology, Wake Forest School of Medicine, Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC 27157, USA
Interests: bioinformatics; single-cell sequencing; machine learning/AI; cancer immunotherapy; COVID-19

Special Issue Information

Dear Colleagues,

Multi-omics, single-cell sequencing technologies, integrative biology, and precision medicine have all been promising approaches for the study of a wide range of human diseases. The big data era, with the rapid development of techniques such as next-generation sequencing, gene editing, cancer immunotherapy/CAR T cell therapy, and everything associated with COVID-19, also led to a huge challenge in data analysis, integration, and bioinformatics and computational models for the discovery of genes and signaling pathways that are essential for human diseases. Understanding the data from genomics, epigenetics, metabolisms, and proteomics, as well as the complex mechanisms in human diseases are the major challenges in current bioinformatics and computational biological studies.

In this Special Issue, we welcome contributions that integrate multi-omics, leverage single-cell sequencing technologies (e.g., scRNA-seq, scATAC-seq, and spatial transcriptomics), develop bioinformatics and computational models, and use machine learning/AI models, aiming at achieving a better understanding of human diseases. It is the aim of this Special Issue to provide a deeper comprehension of multi-omics, single-cell sequencing data, and the association between genetics and phenotypes, as well as biomarker discovery and patient stratification/clinical outcome prediction, that may ultimately lead to early diagnosis and precise and effective treatment.

Dr. Guangxu Jin
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop